HYTN grows exports with cannabis flower sales to Australia
VANCOUVER – HYTN Innovations Inc. (CSE: HYTN) announced that it has successfully sold cannabis flower to serve the Australian medical cannabis market under the Promethean BioPharma brand pursuant to the Company’s supply agreement with TCann Pty Ltd.. “HYTN has been sourcing superior dry flower cannabis inputs for its infused cannabis beverages and gummies for the last 12 months,” remarked Jason...
Read More
